Aloprim is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Allopurinol.
Product ID | 67457-978_018525b1-e37d-4ff2-9dc3-36b3d90ac3e0 |
NDC | 67457-978 |
Product Type | Human Prescription Drug |
Proprietary Name | Aloprim |
Generic Name | Allopurinol |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-11-18 |
Marketing Category | NDA / NDA |
Application Number | NDA020298 |
Labeler Name | Mylan Institutional LLC |
Substance Name | ALLOPURINOL |
Active Ingredient Strength | 500 mg/25mL |
Pharm Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-11-18 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
67457-187 | Aloprim | Aloprim |
67457-978 | Aloprim | Aloprim |
0378-0137 | Allopurinol | allopurinol |
0378-0181 | Allopurinol | allopurinol |
0591-5543 | Allopurinol | Allopurinol |
0591-5544 | Allopurinol | Allopurinol |
0603-2115 | Allopurinol | allopurinol |
0603-2116 | Allopurinol | allopurinol |
0615-1592 | Allopurinol | Allopurinol |
0615-1593 | Allopurinol | Allopurinol |
0615-8321 | Allopurinol | Allopurinol |
0615-8385 | Allopurinol | allopurinol |
0904-6571 | Allopurinol | allopurinol |
0904-6572 | Allopurinol | allopurinol |
0904-7041 | Allopurinol | Allopurinol |
10544-545 | Allopurinol | Allopurinol |
10544-547 | Allopurinol | Allopurinol |
10544-911 | Allopurinol | Allopurinol |
16571-883 | Allopurinol | allopurinol |
16571-884 | Allopurinol | allopurinol |
16571-885 | Allopurinol | allopurinol |
16714-041 | Allopurinol | Allopurinol |
16714-042 | Allopurinol | Allopurinol |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ALOPRIM 75721130 2565678 Live/Registered |
MYLAN TEORANTA 1999-06-03 |
ALOPRIM 75561183 not registered Dead/Abandoned |
ILEX Oncology, Inc. 1998-09-28 |